Tag: investment
-
Macular Degeneration Test Company Gets Investment
The Ontario Genomics Institute (OGI) in Toronto said today it has made an investment in molecular diagnostics company, ArcticDx Inc., also in Toronto. ArcticDx has developed Macula Risk, a test designed to determine one’s inherited risk for age-related macular degeneration (AMD), the most common form of acquired blindness in the developed world, affecting over 10%…
-
Defense/IT Developer Expanding R&D Labs, Staffing
Dynetics, a developer of defense/aerospace and IT systems in Huntsville, Alabama said Thursday it plans to add a new R&D and prototyping facility to its current Huntsville location. The company says it expects to hire 350 new workers over three years to staff the facility, but gave no timetable for when construction work begins. The…
-
U.S. Angel Investors Retreating from Start Up Deals
While angel investors made more deals in the first half of 2010, compared to 2009, the total dollar volume invested dropped, as did the percentage of funding for seed and start up stage financing. Nonetheless, a majority of the deals involved science-related companies. These findings appear in a report published by the Center for Venture…
-
Europe R&D Network Approves 2011 Funding Targets
EUREKA, an intergovernmental consortium of European and neighboring organizations focused on research and development, approved funding €51 million ($US 70.4 million) for 56 new projects next year. The projects were selected by EUREKA’s High Level Group Representatives and National Project Coordinators from 40 countries. The funded R&D projects covered the fields of electronics, IT and…
-
Worldwide Corporate R&D Drops, Pharma/Biotech Bucks Trend
The European Commission’s 2010 “EU Industrial R&D Investment Scoreboard” shows that R&D investment by the world’s top 1,400 companies dropped by nearly 2 percent in the companies’ 2009 fiscal years, but with pharmaceutical/biotech companies and companies in Asian countries increasing their R&D spending. The worldwide economic recession, the report indicates, is taking its toll on…
-
Drug Discovery Company Lands $25M in Private, State Funding
Omeros Corporation, a Seattle, Washington biopharmaceutical company focused on inflammation and disorders of the central nervous system, says it has received $20 million from Vulcan Capital and a grant award for $5 million from Washington State’s Life Sciences Discovery Fund (LSDF) to finance the company’s G protein-coupled receptor program. G-protein-coupled receptors (GPCRs) are a large…
-
Venture Investing Down in Q3, Up for Year-to-Date
In the third quarter of 2010, venture capital (VC) investors put $5.5 billion into 662 deals for U.S.-based companies, down 5 percent in dollars invested but a 2 percent increase in deals from the same period last year, according to Dow Jones VentureSource. Science-based companies were among those experiencing a downturn in VC investments. For…
-
Belgian Nanotech Company To Open Taiwan R&D Center
Interuniversity Microelectronics Centre (Imec), a company conducting research in nanotechnology in Leuven, Belgium said it concluded an agreement with Taiwan’s Ministry of Economic Affairs to open the Imec Taiwan Innovation Centre (ITIC). The ministry announced it will co-fund the facility with Imec. ITIC is expected to expedite applied research projects with industry and academia to…
-
NSF: Companies Investing in R&D Made More Innovations
Preliminary data from the National Science Foundation’s 2008 Business R&D and Innovation Survey (BRDIS) show large differences in making innovations when companies in the U.S. with R&D activity are compared to those without any R&D activity. These data are based on respondents to the survey and represent an estimated 1.5 million for-profit companies, publicly or…
-
Agriproducts Manufacturer Plans R&D Expansion
Kemin Industries in Des Moines, Iowa said the company plans in the next five years to add six new manufacturing facilities, three new research facilities, and a new corporate headquarters building in Des Moines. The company develops nutritional ingredients for foods, animal feeds, and pharmaceuticals based largely on its own research. The $30 million expansion…